SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-051263
Filing Date
2024-06-10
Accepted
2024-06-10 16:40:47
Documents
16
Period of Report
2024-06-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207582-8k_moonlake.htm   iXBRL 8-K 30385
2 PRESS RELEASE, DATED JUNE 10, 2024 ea020758201ex99-1_moonlake.htm EX-99.1 36288
3 GRAPHIC image_001.jpg GRAPHIC 3174
4 GRAPHIC ex99-1_001.jpg GRAPHIC 10639
  Complete submission text file 0001213900-24-051263.txt   273702

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mltx-20240610.xsd EX-101.SCH 3021
6 XBRL LABEL FILE mltx-20240610_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE mltx-20240610_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0207582-8k_moonlake_htm.xml XML 3551
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 241033354
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)